Internal Medicine, Medical Oncology · Green Bay, WI
NPI
1629067269
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1580 Commanche Ave
Green Bay, WI, 54313
Phone (920) 435-8326
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
362 services
Medicare patients, 2024
144
Average age 72
Drug cost, 2024
$4.5M
1,165 prescriptions
Company payments, 2024
$18.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hassan I Tahsildar was code 99214 (office e&m - established), 213 times for 106 patients. In total Hassan I Tahsildar billed 362 services in 17 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 213 | 106 | $62.36 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 44 | 30 | $12.01 | $528 |
| 99215 Office E&M - Established | Office | 32 | 25 | $104.13 | $3,332 |
| 99205 Office E&M - New | Office | 21 | 21 | $125.00 | $2,625 |
By year: 2022 $19K for 296 services; 2023 $19K for 270 services; 2024 $23K for 362 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hassan I Tahsildar prescribed most often to Medicare patients was Anastrozole, with 149 prescriptions and refills. In total Hassan I Tahsildar wrote 1,165 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 149 | 360 | 42 | $2,018 |
| Imbruvica Ibrutinib | 119 | 119 | 13 | $1.9M |
| Acyclovir Generic | 76 | 122 | 22 | $1,179 |
| Ondansetron Hcl Generic | 61 | 62 | 48 | $1,668 |
| Prochlorperazine Maleate Generic | 47 | 47 | 38 | $660 |
| Lenalidomide Generic | 43 | 43 | Under 11 | $477K |
| Zolpidem Tartrate Generic | 39 | 41 | 11 | $172 |
| Dexamethasone Generic | 30 | 33 | 16 | $709 |
| Xarelto Rivaroxaban | 30 | 44 | Under 11 | $25K |
| Tamoxifen Citrate Generic | 29 | 58 | Under 11 | $440 |
| Oxycodone Hcl Generic | 29 | 29 | 15 | $320 |
| Eliquis Apixaban | 29 | 66 | 11 | $39K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 28 | 52 | Under 11 | $188 |
| Pantoprazole Sodium Generic | 26 | 38 | Under 11 | $185 |
| Calquence Acalabrutinib Maleate | 26 | 26 | Under 11 | $294K |
Brand drugs: 341 claims; generic drugs: 824 claims; opioid claims: 53.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Hassan I Tahsildar $18.99 ($18.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Jazz Pharmaceuticals Inc. with $18.99.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $18.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.